PubMed COVID-19 Clinical Care

CONCLUSION: Worsening depression during the COVID era was associated with HIV viral nonsuppression. Strategies to monitor and address depression among PWH may contribute to reduced risk of viral nonsuppression.

Multiple manifestations have been associated with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Among them are mononeuritis multiplex (MNM) and other neurological complications, whose connection to coronavirus disease

CONCLUSIONS AND IMPLICATIONS: Support for lockdown restrictions and enforcement was mainly associated with covid worry. Our findings do not support the parasite stress theory of social values and indicate that the BIS manifested in a more direct way

CONCLUSION: All these findings suggest that attitudes towards the use of TCM are not based on rational cognition and logical reasoning, but are mainly influenced by emotional and cultural factors. This study will help researchers and practitioners

CONCLUSION: This study demonstrated variation in outpatient visit trends for different ACSCs in the first pandemic year. No outpatient visit trends resulted in increased hospitalizations for any ACSC; however, reductions in rates of asthma, COPD, and

Recently, South Korea has been transitioning into a super-aged society. The purpose of this paper is to identify the patterns and underlying causes of gerontophobia expressions in South Korea. This paper refines the patterns of gerontophobia

CONCLUSION: The study identified that quarantine increased anxiety and depression, with age being protective, and education and subjective social connectedness as risk factors. The study also emphasizes the comprehensive impact of objective and

CONCLUSIONS: Silver nanoparticles are safe for corneal epithelial cells in vitro.

CONCLUSIONS: Establishing an association between ACEs and conspiracy endorsement further increases the evidence for early childhood adversities' far-reaching and detrimental effects. By including epistemic trust and personality functioning, these

Molnupiravir, the prodrug for β-D-N⁴-hydroxycytidine (NHC), is marketed by Merck as Lagevrio™ against mild-moderate COVID-19, under FDA emergency use authorization. It is the first oral drug against the disease. This work describes two synthetic